SBC Medical Group Holdings Inc SBC Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$5.04 up $0.02, 0.40% at close Nov 6
Last close · Previous close $5.02
- Market cap
- $518.35MAt the Nov 6 close
- P/E ratio
- 10.72On last 12 months’ EPS
- Diluted EPS
- $0.47Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$5.04down $0.29, 5.44%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$5.02Nov 5
- Volume155.63KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume172.17KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $2.78 to $5.79; now $5.04
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
SBC beat the S&P 500 in all 4 periods.
| Period | SBC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SBC: down 5.4% S&P 500: down 5.6% | SBC beat the S&P 500 by 0.2 percentage points Beat |
| 3M | SBC: up 69.7% S&P 500: down 4.1% | SBC beat the S&P 500 by 73.8 percentage points Beat |
| YTD | SBC: up 16.9% S&P 500: up 8.7% | SBC beat the S&P 500 by 8.2 percentage points Beat |
| 1Y | SBC: up 63.6% S&P 500: up 10.9% | SBC beat the S&P 500 by 52.7 percentage points Beat |
$10,000 invested in SBC a year ago (Nov 6, 2025) would be worth about $16,364 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,088.
SBC beat the S&P 500 in all 4 periods.
| Period | SBC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SBC: down 5.4% S&P 500: down 5.6% | SBC beat the S&P 500 by 0.2 percentage points Beat |
| 3M | SBC: up 69.7% S&P 500: down 4.3% | SBC beat the S&P 500 by 74.0 percentage points Beat |
| YTD | SBC: up 16.9% S&P 500: up 7.8% | SBC beat the S&P 500 by 9.1 percentage points Beat |
| 1Y | SBC: up 63.6% S&P 500: up 9.7% | SBC beat the S&P 500 by 53.9 percentage points Beat |
$10,000 invested in SBC a year ago (Nov 6, 2025) would be worth about $16,364 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $10,969.
All-time high
$9.61
Closing high on . Now 47.6% below that record.
Split-adjusted daily closes since Sep 18, 2024.
Stock splits
SBC hasn’t split since its price history begins in 2024.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
10.7×The Nov 6 close ÷ diluted EPS over the last 12 months ($0.47)
The range covers daily P/E ratios from Sep 18, 2024 to Nov 6, 2026, each based on the previous 12 months of earnings.
SBC trades at 10.7× its earnings over the last 12 months, above its 5-year median of 8.7×. In plain terms, buyers are paying about $11 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 3.0×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 2.0×Book value as of Jun 30, 2026
Price relative to accounting equity (book value) per share on the Jun 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 4.4×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 0.23Last 12 months’ EPS growth
The P/E divided by the growth in diluted EPS over the last 12 months (+46.9% on the 12 months before). It looks backward: near 1 means the P/E roughly matches last year’s growth. Sites that use analysts’ growth forecasts show a different PEG.
PEG = P/E ÷ EPS growth (%) = 10.7 ÷ 46.9 - 12.82%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $363.24MAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own SBC DCF in Excel. Value SBC Medical Group Holdings with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $175.17Mdown 6.9%
- Net income
- $49.03Mup 47.1%
- Diluted EPS
- $0.47up 46.9%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $53.08M | $2.83M | $0.03 |
| Q4 FY24 (Dec 31, 2024) | $44.42M | $6.54M | $0.06 |
| Q1 FY25 (Mar 31, 2025) | $47.33M | $21.50M | $0.21 |
| Q2 FY25 (Jun 30, 2025) | $43.36M | $2.46M | $0.02 |
| Q3 FY25 (Sep 30, 2025) | $43.35M | $12.82M | $0.12 |
| Q4 FY25 (Dec 31, 2025) | $39.57M | $14.20M | $0.14 |
| Q1 FY26 (Mar 31, 2026) | $43.06M | $11.31M | $0.11 |
| Q2 FY26 (Jun 30, 2026) | $49.19M | $10.69M | $0.10 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY22 (Dec 31, 2022) | $174.16M | $6.32M | $0.79 |
| FY23 (Dec 31, 2023) | $193.54M | $39.37M | $0.42 |
| FY24 (Dec 31, 2024) | $205.42M | $46.61M | $0.48 |
| FY25 (Dec 31, 2025) | $173.61M | $50.99M | $0.50 |
Margins
- Gross 71.9%
- Operating 37.3%
- Net 28.0%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $66.45MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$62.82MLast 12 months
- Capital spending$3.63MLast 12 months
- 37.9%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $2.58MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$2.58MLast 12 months
4% of free cash flow
Balance sheet
- $256.14MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$48.23MAs of Jun 30, 2026
- Net cash$207.90MAs of Jun 30, 2026
- 3.31As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.18As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 5 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✗Current ratio improved: not passed
- ✓Share count didn’t rise: passed
- ✗Gross margin improved: not passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 19.3%Last 12 months
Over the last 12 months, SBC Medical Group Holdings’s net income was 19.3% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 13.1%Last 12 months
Over the last 12 months, SBC Medical Group Holdings’s net income was 13.1% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About SBC Medical Group Holdings Inc
SBC Medical Group Holdings, Inc. provides management services to cosmetic treatment centers through a franchise model operating across Japan, Southeast Asia, and the United States. The Company operates a diversified portfolio of cosmetic, dermatology, and wellness-focused brands and continues to expand through both organic growth and strategic acquisitions. About Emerging Growth Research Emerging Growth Research is an independent equity research firm providing institutional-quality analysis on emerging growth companies.
- Sector
- Industrials
- Industry
- Consulting Services
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
SBC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
SBC stock FAQ
What is SBC stock’s price today?
SBC Medical Group Holdings (SBC) traded at $5.04 at the close on , up $0.02 (0.40%) from the previous close of $5.02. Over the past 52 weeks it has traded between $2.78 and $5.79.
What is SBC Medical Group Holdings’s market cap?
SBC Medical Group Holdings’s market capitalization is about $518.3 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $5.04 (how market cap works). SBC Medical Group Holdings reported 102.85M shares outstanding at the end of its latest quarter ().
What is SBC’s P/E ratio?
SBC trades at 10.7 times its diluted earnings over the four quarters to ($0.47 per share), at the close. Over the past five years its P/E has ranged from 0.5 to 17.6, with a median of 8.7. (How the P/E ratio works.)
How much revenue does SBC Medical Group Holdings make?
SBC Medical Group Holdings reported $175.2 million of revenue over the four quarters to , down 6.9% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $49.2 million, up 13.4% from a year earlier.
Is SBC Medical Group Holdings profitable?
Yes. SBC Medical Group Holdings earned $49.0 million of net income over the four quarters to , a net margin of 28.0%, and its operating margin was 37.3% (what margins tell you).
What are SBC’s earnings per share?
SBC’s diluted earnings per share were $0.47 over the four quarters to , compared with $0.32 in the twelve months before. The latest quarter (Q2 FY26) brought $0.10 per share, against $0.02 a year earlier (how EPS works).
Does SBC pay a dividend?
SBC Medical Group Holdings hasn’t paid a dividend in the last twelve months.
What is SBC’s 52-week high and low?
Over the past 52 weeks SBC has traded as low as $2.78 and as high as $5.79. At $5.04 at the close on , it is 13.0% below that high and 81.3% above the low.
What is SBC’s all-time high?
SBC’s highest closing price was $9.61 on , adjusted for stock splits. At $5.04 at the close on , it is 47.6% below that record.
Has SBC stock ever split?
No. SBC hasn’t split since its price history begins in 2024.
How has SBC stock performed?
Including dividends and measured to the close on , SBC has returned +16.9% so far this year and +63.6% over the past year. Over the same periods the S&P 500, measured by SPY, returned +8.7% and +10.9%. Past performance doesn’t predict future returns.
What sector and industry is SBC Medical Group Holdings in?
SBC Medical Group Holdings is in the Industrials sector and the Consulting Services industry, and is headquartered in California, USA.
What exchange does SBC trade on?
SBC Medical Group Holdings trades on the Nasdaq under the ticker symbol SBC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.